These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 22835845

  • 1. Antidepressant combination for major depression in incomplete responders--a systematic review.
    Lopes Rocha F, Fuzikawa C, Riera R, Ramos MG, Hara C.
    J Affect Disord; 2013 Jan 10; 144(1-2):1-6. PubMed ID: 22835845
    [Abstract] [Full Text] [Related]

  • 2. Combination of antidepressants in the treatment of major depressive disorder: a systematic review and meta-analysis.
    Rocha FL, Fuzikawa C, Riera R, Hara C.
    J Clin Psychopharmacol; 2012 Apr 10; 32(2):278-81. PubMed ID: 22367652
    [Abstract] [Full Text] [Related]

  • 3. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr 10; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 4. Wuling Capsule for Major Depressive Disorder: A Meta-analysis of Randomised Controlled Trials.
    Zheng W, Zhang YF, Zhong HQ, Mai SM, Yang XH, Xiang YT.
    East Asian Arch Psychiatry; 2016 Sep 10; 26(3):87-97. PubMed ID: 27703096
    [Abstract] [Full Text] [Related]

  • 5. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P.
    Lancet; 2016 Aug 27; 388(10047):881-90. PubMed ID: 27289172
    [Abstract] [Full Text] [Related]

  • 6. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P, Ward HE, Tremblay P, Laberge L, Hébert C, Bergeron R.
    Am J Psychiatry; 2010 Mar 27; 167(3):281-8. PubMed ID: 20008946
    [Abstract] [Full Text] [Related]

  • 7. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N, Papakostas GI.
    J Clin Psychiatry; 2012 May 27; 73(5):676-83. PubMed ID: 22569112
    [Abstract] [Full Text] [Related]

  • 8. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.
    Eur Neuropsychopharmacol; 2009 Jul 27; 19(7):457-65. PubMed ID: 19345072
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
    Carpenter LL, Yasmin S, Price LH.
    Biol Psychiatry; 2002 Jan 15; 51(2):183-8. PubMed ID: 11822997
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI.
    J Clin Psychiatry; 2011 Dec 15; 72(12):1660-8. PubMed ID: 22244025
    [Abstract] [Full Text] [Related]

  • 11. A systematic review of augmentation strategies for patients with major depressive disorder.
    Fleurence R, Williamson R, Jing Y, Kim E, Tran QV, Pikalov AS, Thase ME.
    Psychopharmacol Bull; 2009 Dec 15; 42(3):57-90. PubMed ID: 19752841
    [Abstract] [Full Text] [Related]

  • 12. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ.
    Am J Psychiatry; 2006 Sep 15; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [Abstract] [Full Text] [Related]

  • 13. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
    Schüle C, Baghai TC, Eser D, Hecht S, Hermisson I, Born C, Häfner S, Nothdurfter C, Rupprecht R.
    World J Biol Psychiatry; 2007 Sep 15; 8(2):112-22. PubMed ID: 17455104
    [Abstract] [Full Text] [Related]

  • 14. Combining antidepressant medications: a good idea?
    Rush AJ.
    Am J Psychiatry; 2010 Mar 15; 167(3):241-3. PubMed ID: 20194484
    [No Abstract] [Full Text] [Related]

  • 15. Switching the Antidepressant After Nonresponse in Adults With Major Depression: A Systematic Literature Search and Meta-Analysis.
    Bschor T, Kern H, Henssler J, Baethge C.
    J Clin Psychiatry; 2018 Mar 15; 79(1):. PubMed ID: 27929611
    [Abstract] [Full Text] [Related]

  • 16. Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study.
    Ng CG, Boks MP, Roes KC, Zainal NZ, Sulaiman AH, Tan SB, de Wit NJ.
    Eur Neuropsychopharmacol; 2014 Apr 15; 24(4):491-8. PubMed ID: 24503279
    [Abstract] [Full Text] [Related]

  • 17. Reboxetine addition in patients with mirtazapine-resistant depression: a case series.
    López-Muñoz F, Rubio G, Alamo C, García-García P, Pardo A.
    Clin Neuropharmacol; 2006 Apr 15; 29(4):192-6. PubMed ID: 16855420
    [Abstract] [Full Text] [Related]

  • 18. Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial.
    Cornelius JR, Chung T, Douaihy AB, Kirisci L, Glance J, Kmiec J, FitzGerald D, Wesesky MA, Salloum I.
    Psychiatry Res; 2016 Aug 30; 242():326-330. PubMed ID: 27327217
    [Abstract] [Full Text] [Related]

  • 19. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
    Iovieno N, Papakostas GI.
    J Clin Psychiatry; 2012 Oct 30; 73(10):1300-6. PubMed ID: 23140647
    [Abstract] [Full Text] [Related]

  • 20. Antidepressants for depression in Parkinson's disease: systematic review and meta-analysis.
    Rocha FL, Murad MG, Stumpf BP, Hara C, Fuzikawa C.
    J Psychopharmacol; 2013 May 30; 27(5):417-23. PubMed ID: 23427193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.